imiquimod has been researched along with Arthritis, Psoriatic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 5 (83.33) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, Y; Arita, T; Asai, J; Katoh, N; Masuda, K; Nakamura, K | 1 |
| Banfi, G; Casciano, F; Gornati, L; Granucci, F; Guerrini, R; Marzola, E; Mingozzi, F; Montico, G; Protti, G; Reali, E; Secchiero, P; Volinia, S | 1 |
| Acinas, O; Alvarez, P; Augustín, JJ; Genre, F; Iglesias, M; Mendiguren, MA; Merino, J; Merino, R; San Segundo, D; Tamayo, E; Vázquez, JA | 1 |
| Dandekar, S; Garcia-Melchor, E; Haas, KN; Huynh, M; Hwang, ST; Law, T; Millar, NL; Nguyen, M; Rolston, M; Santos Rocha, C; Shi, Z; Wan, YY; Wu, X; Yamada, D | 1 |
| Banfi, G; Bridgewood, C; Damiani, G; Dunsmuir, R; El-Sherbiny, YM; Khan, A; Loughenbury, P; Malagoli, P; McGonagle, D; Millner, PA; Pigatto, PDM; Rao, A; Rowe, H; Russell, T; Sharif, K; Timothy, J; Vadakekolathu, J; Watad, A; Zhou, Q | 1 |
| Ahmad, SF; Al-Harbi, NO; Attia, SM; Bakheet, SA; El-Sherbeeny, AM; Nadeem, A | 1 |
6 other study(ies) available for imiquimod and Arthritis, Psoriatic
| Article | Year |
|---|---|
Exacerbation of psoriatic arthritis due to topical imiquimod therapy.
Topics: Administration, Topical; Aminoquinolines; Animals; Arthritis, Psoriatic; Disease Models, Animal; Humans; Imiquimod; Psoriasis; Skin | 2023 |
CCR4
Topics: Animals; Arthritis, Psoriatic; CD8-Positive T-Lymphocytes; Humans; Imiquimod; Inflammation; Mice; Mice, Inbred C57BL; Psoriasis; Receptors, Antigen, T-Cell; Receptors, CCR4; Skin Diseases | 2023 |
Therapeutic Effects of Anti-Bone Morphogenetic Protein and Activin Membrane-Bound Inhibitor Treatment in Psoriasis and Arthritis.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Monoclonal; Arthritis, Experimental; Arthritis, Psoriatic; CD4-Positive T-Lymphocytes; Cell Differentiation; Collagen Type II; Disease Models, Animal; Imiquimod; Interleukin-17; Interleukin-2; Mannans; Membrane Proteins; Mice; Mice, Knockout; Psoriasis; Saccharomyces cerevisiae; Skin; T-Lymphocytes, Regulatory; Th17 Cells; Transforming Growth Factor beta | 2020 |
Short-Term Western Diet Intake Promotes IL-23‒Mediated Skin and Joint Inflammation Accompanied by Changes to the Gut Microbiota in Mice.
Topics: Animals; Arthritis, Psoriatic; Diet, Western; Disease Models, Animal; Dysbiosis; Gastrointestinal Microbiome; Humans; Imiquimod; Interleukin-23; Mice; Psoriasis; Signal Transduction | 2021 |
SARS-CoV-2 Infection Induces Psoriatic Arthritis Flares and Enthesis Resident Plasmacytoid Dendritic Cell Type-1 Interferon Inhibition by JAK Antagonism Offer Novel Spondyloarthritis Pathogenesis Insights.
Topics: Adjuvants, Immunologic; Adult; Aged; Arthritis, Psoriatic; Computational Biology; COVID-19; Cyclic Nucleotide Phosphodiesterases, Type 4; Dendritic Cells; Female; Gene Expression Regulation; Humans; Imiquimod; Interferon-alpha; Janus Kinases; Male; Middle Aged; NF-kappa B; Oligonucleotides; Phosphodiesterase 4 Inhibitors; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction; Toll-Like Receptor 7; Toll-Like Receptor 9; Transcriptome; Tumor Necrosis Factor-alpha | 2021 |
Systemic inflammation in asocial BTBR T
Topics: Adaptive Immunity; Animals; Arthritis, Psoriatic; Autism Spectrum Disorder; Disease Models, Animal; Disease Susceptibility; Imiquimod; Immunity, Innate; Inflammation; Male; Membrane Glycoproteins; Mice, Inbred C57BL; Skin; Social Behavior; Species Specificity; Th17 Cells; Toll-Like Receptor 7 | 2018 |